Skip to content

Assessment of Total Pulmonary Resistance sPAP/CO Between Sea Level LA vs. High Altitude HA After Re-ascent in Healthy Individuals

Effect of a One-week Descent From 2850m to Sea Level and Re-ascent in Patients With Pulmonary Arterial Hypertension and Healthy Controls Permanently Living > 2600m on Pulmonary Hemodynamics, Exercise Capacity, Blood Oxygenation, Sleep Disordered Breathing and Further Outcomes

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07804589
Enrollment
14
Registered
2026-09-04
Start date
2026-09-25
Completion date
2026-12-31
Last updated
2026-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Echocardiography, Healthy, Healthy Adult, Hemodynamic Changes, High Altitude, High Altitude Effects, Pulmonary Resistance

Keywords

Hypoxia, High Altitude, Pulmonary resistance, Health, Echocardiography, Hemodynamics

Brief summary

To study the effect of a re-ascent after a one-week stay at sea level (after prior descent from 2850m) to high altitude (Quito Ecuador: 2850m) on pulmonary resistance (sPAP/CO) and other hemodynamic outcomes in healthy individuals, who live permanently \>2600m.

Detailed description

The aim of this research is to investigate the pulmonary resistance (sPAP/CO) by echocardiography and other hemodynamic outcomes before and after re-ascent (sea level for 7 days vs. re-ascent to 2850m) in healthy individuals, who permanently live at high altitude over 2600m

Interventions

After 7 days at sea level return/re-ascent to their usual living altitude at 2850m

Sponsors

Silvia Ulrich Somaini
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Healthy individuals living permanently \> 2600m around Quito (Ecuador) will be assessed after 7 days at sea level and after re-ascent to 2850m

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults aged 18-80 years and of all genders * Permanent residence \> 2600 m. * healthy: no self-perceived cardiopulmonary disease limiting daily activities * written informed consent to participate in the study.

Exclusion criteria

* Age \<18 years or \>80 years * Participants who cannot follow the study investigations * Participants permanently living \< 2600m. * Participants who traveled and stayed overnight at altitudes \<2000 m in the past 4 weeks. * any self-perceived cardiopulmonary disease limiting daily activities

Design outcomes

Primary

MeasureTime frameDescription
Pulmonary resistance (sPAP/CO) after re-ascent to 2850mFrom Day 5-7 at sea level to the day after re-ascentDifference in sPAP/CO by echocardiography between sea level (after one-week stay) and day after re-ascent at 2850m in healthy individuals

Secondary

MeasureTime frameDescription
PaO2 after re-ascent to 2850mFrom Day 7 at sea level to day after re-ascent (time frame of 3 days)Difference/change in PaO2 (arterial blood gas analysis) between sea level (after one-week stay) and day after re-ascent to 2850m in healthy individuals
PaCO2 after re-ascent to 2850mFrom Day 7 at sea level to day after re-ascent (time frame of 3 days)Difference/change in PaCO2 (arterial blood gas analysis) between sea level (after one-week stay) and day after re-ascent to 2850m in healthy individuals
Hemoglobin after re-ascent to 2850mFrom Day 7 at sea level to day after re-ascent (time frame of 3 days)Difference/change in hemoglobin (arterial blood gas analysis) between sea level (after one-week stay) and day after re-ascent to 2850m in healthy individuals
pH after re-ascent to 2850mFrom Day 7 at sea level to day after re-ascent (time frame of 3 days)Difference/change in pH (arterial blood gas analysis) between sea level (after one-week stay) and day after re-ascent to 2850m in healthy individuals
Tricuspid regurgitation velocity TRV after re-ascent to 2850mFrom Day 5-7 at sea level to the day after re-ascentDifference/change in tricuspid regurgitation velocity TRV between sea level (after one-week stay) and day after re-ascent at 2850m in healthy individuals
Cardiac output CO after re-ascent to 2850mFrom Day 5-7 at sea level to the day after re-ascentDifference/change in cardiac output CO between sea level (after one-week stay) and Day after re-ascent to 2850m in healthy individuals
Tricuspid annular plan systolic excursion TAPSE after re-ascent to 2850mFrom Day 5-7 at sea level to day after re-ascentDifference/change in tricuspid annular plan systolic excursion TAPSE between sea level (after one-week stay) and Day after re-ascent to 2850m in healthy individuals
Right ventricular strain after re-ascent to 2850mFrom Day 5-7 at sea level to day after re-ascentDifference/change in right ventricular strain between sea level (after one-week stay) and Day after re-ascent to 2850m in healthy individuals
Right atrial pressure RAP after re-ascent to 2850mFrom Day 5-7 at sea level to day after re-ascentDifference/change in rightatrial pressure RAP between sea level (after one-week stay) and Day after re-ascent to 2850m in healthy individuals
Pulmonary resistance (sPAP/CO) pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in pulmonary resistance (sPAP/CO) at 2850m with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals
Tricuspid regurgitation velocity TRV pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in tricuspid regurgitation velocity TRV at 2850m with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals
Cardiac output CO pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in cardiac output CO at 2850m with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals
Tricuspid annular plan systolic excursion TAPSE pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in tricuspid annular plan systolic excursion TAPSE at 2850m with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals
Right ventricular strain pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in right ventricular strain at 2850m with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals
Right atrial pressure RAP pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in right atrial pressure at 2850m with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals
Fractional area change FAC pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in fractional area change FAC at 2850m with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals
PaO2 pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in PaO2 (arterial blood gas analysis) at 2850m with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals
PaCO2 pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in PaCO2 (arterial blood gas analysis) at 2850m with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals
Hemoglobin pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in hemoglobin (arterial blood gas analysis) at 2850m with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals
Fractional area change FAC after re-ascent to 2850mFrom Day 5-7 at sea level to day after re-ascentDifference/change in fractional area change FAC between sea level (after one-week stay) and Day after re-ascent to 2850m in healthy individuals
pH pre-descent to after re-ascentBaseline at 2850m followed by a one-week stay at sea level to the day after re-ascent back to 2850m (time frame approximately 11 days)Difference/change in pH (arterial blood gas analysis) at 2850m with a one-week stay at sea level in between (day pre-descent vs. day after re-ascent) in healthy individuals

Countries

Switzerland

Contacts

CONTACTSilvia Ulrich, Prof. Dr. med.
silvia.ulrich@usz.ch+41442552220
CONTACTMichael Furian, Prof. Dr. sc. ETH
+41442552220
PRINCIPAL_INVESTIGATORSilvia Ulrich

University Hospital Zurich, Departement of Pulmonology

PRINCIPAL_INVESTIGATORRodrigo Hoyos

Hospital Carlos Andrade Marin of Quito, Ecuador

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 5, 2026